Parathyroid hormone linked to arterial stiffness in T1DM

January 11, 2017

(HealthDay)—In individuals with type 1 diabetes, parathyroid hormone (PTH) is associated with arterial stiffness, even after adjustment for multiple confounding variables, according to research published online Jan. 6 in Diabetes Care.

Emilie H. Zobel, M.D., from the Steno Diabetes Center in Gentofte, Denmark, and colleagues examined the correlation between , evaluated by carotid-femoral pulse wave velocity (cfPWV), and bone mass density in a well-characterized cohort of 347 individuals with type 1 diabetes.

The researchers found that , all clinical bone markers, and markers of mineral metabolism, except calcium, phosphorus, and Dickkopf 1, correlated with cfPWV in unadjusted analyses (P ≤ 0.041). The level of bone mineral density, the clinical bone marker PTH, and the marker of bone mineral metabolism sclerostin correlated with cfPWV after adjustment for age, sex, and mean arterial pressure (P ≤ 0.027). PTH remained positively associated with cfPWV after further adjustment for additional risk factors, including hemoglobin A1c, total cholesterol, body mass index, antihypertensive treatment, rate, estimated , and smoking (P = 0.014).

"Our findings highlight PTH as a potential mediator for the cross talk between bone and vascular disease," the authors write. "However, our findings need validation, and prospective studies investigating the relationship between PTH and cardiovascular outcome in type 1 diabetes are warranted."

Explore further: Summer concentrations of 25OHD predict bone mineral density

More information: Full Text (subscription or payment may be required)

Related Stories

Summer concentrations of 25OHD predict bone mineral density

October 4, 2016
(HealthDay)—Summer levels of serum 25-hydroxyvitamin D (S-25OHD) are associated with bone mineral density of the total hip, according to a study published online Sept. 25 in the Journal of Internal Medicine.

Some apolipoproteins linked to incident type 2 diabetes

January 5, 2017
(HealthDay)—Apolipoprotein (apo) CIII and apoCIII-to-apoA1 ratio are correlated with incident type 2 diabetes (T2D), according to a study published online Dec. 28 in Diabetes Care.

Uric acid levels low in teens with type 1 diabetes

March 1, 2016
(HealthDay)—Plasma uric acid (PUA) levels are significantly lower in adolescent patients with type 1 diabetes (T1D) than in healthy control subjects, and there does not appear to be a link between PUA levels and cardiorenal ...

Menopausal hormone therapy improves bone health

November 17, 2016
Women who undergo hormone therapy for menopausal symptoms such as hot flashes can not only increase bone mass, but also can improve bone structure, according to a new study published in the Endocrine Society's Journal of ...

Romosozumab increases bone mineral density post-menopause

January 6, 2014
(HealthDay)—Romosozumab seems safe and effective for increasing bone mineral density in postmenopausal women with low bone mineral density, according to a study published online Jan. 1 in the New England Journal of Medicine.

Arterial stiffness inversely tied to plasma adiponectin levels

September 27, 2012
(HealthDay)—Arterial stiffness is inversely related to plasma adiponectin levels in young, normotensive patients with type 1 diabetes, according to a study published online Sept. 21 in Diabetes Care.

Recommended for you

Diabetes can be tracked with our Google searches

July 26, 2017
The emergence of Type 2 Diabetes could be more effectively monitored using our Google searches—helping public health officials keep track of the disease and halt its spread—according to research by the University of Warwick.

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.